Global Narcotic (Opioid) Drugs Market Size, Status and Forecast 2024-2031

Report ID: 923153 | Published Date: Sep 2024 | No. of Page: 107 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Codeine
        1.2.3 Fentanyl
        1.2.4 Hydrocodone
        1.2.5 Hydromorphone
        1.2.6 Meperidine
        1.2.7 Methadone
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Narcotic (Opioid) Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Pain Relief Application
        1.3.3 Anesthesia Application
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Narcotic (Opioid) Drugs Market Perspective (2016-2027)
    2.2 Narcotic (Opioid) Drugs Growth Trends by Regions
        2.2.1 Narcotic (Opioid) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Narcotic (Opioid) Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Narcotic (Opioid) Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Narcotic (Opioid) Drugs Industry Dynamic
        2.3.1 Narcotic (Opioid) Drugs Market Trends
        2.3.2 Narcotic (Opioid) Drugs Market Drivers
        2.3.3 Narcotic (Opioid) Drugs Market Challenges
        2.3.4 Narcotic (Opioid) Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Narcotic (Opioid) Drugs Players by Revenue
        3.1.1 Global Top Narcotic (Opioid) Drugs Players by Revenue (2016-2021)
        3.1.2 Global Narcotic (Opioid) Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Narcotic (Opioid) Drugs Revenue
    3.4 Global Narcotic (Opioid) Drugs Market Concentration Ratio
        3.4.1 Global Narcotic (Opioid) Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Narcotic (Opioid) Drugs Revenue in 2020
    3.5 Narcotic (Opioid) Drugs Key Players Head office and Area Served
    3.6 Key Players Narcotic (Opioid) Drugs Product Solution and Service
    3.7 Date of Enter into Narcotic (Opioid) Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Narcotic (Opioid) Drugs Breakdown Data by Type
    4.1 Global Narcotic (Opioid) Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2022-2027)

5 Narcotic (Opioid) Drugs Breakdown Data by Application
    5.1 Global Narcotic (Opioid) Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Narcotic (Opioid) Drugs Market Size (2016-2027)
    6.2 North America Narcotic (Opioid) Drugs Market Size by Type
        6.2.1 North America Narcotic (Opioid) Drugs Market Size by Type (2016-2021)
        6.2.2 North America Narcotic (Opioid) Drugs Market Size by Type (2022-2027)
        6.2.3 North America Narcotic (Opioid) Drugs Market Size by Type (2016-2027)
    6.3 North America Narcotic (Opioid) Drugs Market Size by Application
        6.3.1 North America Narcotic (Opioid) Drugs Market Size by Application (2016-2021)
        6.3.2 North America Narcotic (Opioid) Drugs Market Size by Application (2022-2027)
        6.3.3 North America Narcotic (Opioid) Drugs Market Size by Application (2016-2027)
    6.4 North America Narcotic (Opioid) Drugs Market Size by Country
        6.4.1 North America Narcotic (Opioid) Drugs Market Size by Country (2016-2021)
        6.4.2 North America Narcotic (Opioid) Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Narcotic (Opioid) Drugs Market Size (2016-2027)
    7.2 Europe Narcotic (Opioid) Drugs Market Size by Type
        7.2.1 Europe Narcotic (Opioid) Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Narcotic (Opioid) Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Narcotic (Opioid) Drugs Market Size by Type (2016-2027)
    7.3 Europe Narcotic (Opioid) Drugs Market Size by Application
        7.3.1 Europe Narcotic (Opioid) Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Narcotic (Opioid) Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Narcotic (Opioid) Drugs Market Size by Application (2016-2027)
    7.4 Europe Narcotic (Opioid) Drugs Market Size by Country
        7.4.1 Europe Narcotic (Opioid) Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Narcotic (Opioid) Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type
        8.2.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application
        8.3.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region
        8.4.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Narcotic (Opioid) Drugs Market Size (2016-2027)
    9.2 Latin America Narcotic (Opioid) Drugs Market Size by Type
        9.2.1 Latin America Narcotic (Opioid) Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Narcotic (Opioid) Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Narcotic (Opioid) Drugs Market Size by Type (2016-2027)
    9.3 Latin America Narcotic (Opioid) Drugs Market Size by Application
        9.3.1 Latin America Narcotic (Opioid) Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Narcotic (Opioid) Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Narcotic (Opioid) Drugs Market Size by Application (2016-2027)
    9.4 Latin America Narcotic (Opioid) Drugs Market Size by Country
        9.4.1 Latin America Narcotic (Opioid) Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Narcotic (Opioid) Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type
        10.2.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application
        10.3.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country
        10.4.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Narcotic (Opioid) Drugs Introduction
        11.1.4 Pfizer Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Teva
        11.2.1 Teva Company Details
        11.2.2 Teva Business Overview
        11.2.3 Teva Narcotic (Opioid) Drugs Introduction
        11.2.4 Teva Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.2.5 Teva Recent Development
    11.3 Purdue Pharma
        11.3.1 Purdue Pharma Company Details
        11.3.2 Purdue Pharma Business Overview
        11.3.3 Purdue Pharma Narcotic (Opioid) Drugs Introduction
        11.3.4 Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.3.5 Purdue Pharma Recent Development
    11.4 Mallinckrodt
        11.4.1 Mallinckrodt Company Details
        11.4.2 Mallinckrodt Business Overview
        11.4.3 Mallinckrodt Narcotic (Opioid) Drugs Introduction
        11.4.4 Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.4.5 Mallinckrodt Recent Development
    11.5 Amneal Pharma
        11.5.1 Amneal Pharma Company Details
        11.5.2 Amneal Pharma Business Overview
        11.5.3 Amneal Pharma Narcotic (Opioid) Drugs Introduction
        11.5.4 Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.5.5 Amneal Pharma Recent Development
    11.6 Collegium
        11.6.1 Collegium Company Details
        11.6.2 Collegium Business Overview
        11.6.3 Collegium Narcotic (Opioid) Drugs Introduction
        11.6.4 Collegium Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.6.5 Collegium Recent Development
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Company Details
        11.7.2 Johnson & Johnson Business Overview
        11.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Introduction
        11.7.4 Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.7.5 Johnson & Johnson Recent Development
    11.8 Merck
        11.8.1 Merck Company Details
        11.8.2 Merck Business Overview
        11.8.3 Merck Narcotic (Opioid) Drugs Introduction
        11.8.4 Merck Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.8.5 Merck Recent Development
    11.9 Mylan
        11.9.1 Mylan Company Details
        11.9.2 Mylan Business Overview
        11.9.3 Mylan Narcotic (Opioid) Drugs Introduction
        11.9.4 Mylan Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.9.5 Mylan Recent Development
    11.10 Hikma Pharmaceuticals
        11.10.1 Hikma Pharmaceuticals Company Details
        11.10.2 Hikma Pharmaceuticals Business Overview
        11.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Introduction
        11.10.4 Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.10.5 Hikma Pharmaceuticals Recent Development
    11.11 Sun Pharma
        11.11.1 Sun Pharma Company Details
        11.11.2 Sun Pharma Business Overview
        11.11.3 Sun Pharma Narcotic (Opioid) Drugs Introduction
        11.11.4 Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.11.5 Sun Pharma Recent Development
    11.12 Endo Pharmaceuticals
        11.12.1 Endo Pharmaceuticals Company Details
        11.12.2 Endo Pharmaceuticals Business Overview
        11.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Introduction
        11.12.4 Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.12.5 Endo Pharmaceuticals Recent Development
    11.13 Allergan
        11.13.1 Allergan Company Details
        11.13.2 Allergan Business Overview
        11.13.3 Allergan Narcotic (Opioid) Drugs Introduction
        11.13.4 Allergan Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
        11.13.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Codeine
    Table 3. Key Players of Fentanyl
    Table 4. Key Players of Hydrocodone
    Table 5. Key Players of Hydromorphone
    Table 6. Key Players of Meperidine
    Table 7. Key Players of Methadone
    Table 8. Key Players of Others
    Table 9. Global Narcotic (Opioid) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Narcotic (Opioid) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Narcotic (Opioid) Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global Narcotic (Opioid) Drugs Market Share by Regions (2016-2021)
    Table 13. Global Narcotic (Opioid) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global Narcotic (Opioid) Drugs Market Share by Regions (2022-2027)
    Table 15. Narcotic (Opioid) Drugs Market Trends
    Table 16. Narcotic (Opioid) Drugs Market Drivers
    Table 17. Narcotic (Opioid) Drugs Market Challenges
    Table 18. Narcotic (Opioid) Drugs Market Restraints
    Table 19. Global Narcotic (Opioid) Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global Narcotic (Opioid) Drugs Market Share by Players (2016-2021)
    Table 21. Global Top Narcotic (Opioid) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcotic (Opioid) Drugs as of 2020)
    Table 22. Ranking of Global Top Narcotic (Opioid) Drugs Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by Narcotic (Opioid) Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Narcotic (Opioid) Drugs Product Solution and Service
    Table 26. Date of Enter into Narcotic (Opioid) Drugs Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Narcotic (Opioid) Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2016-2021)
    Table 30. Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global Narcotic (Opioid) Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global Narcotic (Opioid) Drugs Revenue Market Share by Application (2016-2021)
    Table 34. Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global Narcotic (Opioid) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America Narcotic (Opioid) Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America Narcotic (Opioid) Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America Narcotic (Opioid) Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America Narcotic (Opioid) Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America Narcotic (Opioid) Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 41. North America Narcotic (Opioid) Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 42. Europe Narcotic (Opioid) Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe Narcotic (Opioid) Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe Narcotic (Opioid) Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe Narcotic (Opioid) Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe Narcotic (Opioid) Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 47. Europe Narcotic (Opioid) Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 48. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 53. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 54. Latin America Narcotic (Opioid) Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America Narcotic (Opioid) Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America Narcotic (Opioid) Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America Narcotic (Opioid) Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America Narcotic (Opioid) Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 59. Latin America Narcotic (Opioid) Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 60. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 65. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 66. Pfizer Company Details
    Table 67. Pfizer Business Overview
    Table 68. Pfizer Narcotic (Opioid) Drugs Product
    Table 69. Pfizer Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 70. Pfizer Recent Development
    Table 71. Teva Company Details
    Table 72. Teva Business Overview
    Table 73. Teva Narcotic (Opioid) Drugs Product
    Table 74. Teva Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 75. Teva Recent Development
    Table 76. Purdue Pharma Company Details
    Table 77. Purdue Pharma Business Overview
    Table 78. Purdue Pharma Narcotic (Opioid) Drugs Product
    Table 79. Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 80. Purdue Pharma Recent Development
    Table 81. Mallinckrodt Company Details
    Table 82. Mallinckrodt Business Overview
    Table 83. Mallinckrodt Narcotic (Opioid) Drugs Product
    Table 84. Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 85. Mallinckrodt Recent Development
    Table 86. Amneal Pharma Company Details
    Table 87. Amneal Pharma Business Overview
    Table 88. Amneal Pharma Narcotic (Opioid) Drugs Product
    Table 89. Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 90. Amneal Pharma Recent Development
    Table 91. Collegium Company Details
    Table 92. Collegium Business Overview
    Table 93. Collegium Narcotic (Opioid) Drugs Product
    Table 94. Collegium Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 95. Collegium Recent Development
    Table 96. Johnson & Johnson Company Details
    Table 97. Johnson & Johnson Business Overview
    Table 98. Johnson & Johnson Narcotic (Opioid) Drugs Product
    Table 99. Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 100. Johnson & Johnson Recent Development
    Table 101. Merck Company Details
    Table 102. Merck Business Overview
    Table 103. Merck Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 104. Merck Recent Development
    Table 105. Mylan Company Details
    Table 106. Mylan Business Overview
    Table 107. Mylan Narcotic (Opioid) Drugs Product
    Table 108. Mylan Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 109. Mylan Recent Development
    Table 110. Hikma Pharmaceuticals Company Details
    Table 111. Hikma Pharmaceuticals Business Overview
    Table 112. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product
    Table 113. Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 114. Hikma Pharmaceuticals Recent Development
    Table 115. Sun Pharma Company Details
    Table 116. Sun Pharma Business Overview
    Table 117. Sun Pharma Narcotic (Opioid) Drugs Product
    Table 118. Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 119. Sun Pharma Recent Development
    Table 120. Endo Pharmaceuticals Company Details
    Table 121. Endo Pharmaceuticals Business Overview
    Table 122. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product
    Table 123. Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 124. Endo Pharmaceuticals Recent Development
    Table 125. Allergan Company Details
    Table 126. Allergan Business Overview
    Table 127. Allergan Narcotic (Opioid) Drugs Product
    Table 128. Allergan Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
    Table 129. Allergan Recent Development
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Narcotic (Opioid) Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Codeine Features
    Figure 3. Fentanyl Features
    Figure 4. Hydrocodone Features
    Figure 5. Hydromorphone Features
    Figure 6. Meperidine Features
    Figure 7. Methadone Features
    Figure 8. Others Features
    Figure 9. Global Narcotic (Opioid) Drugs Market Share by Application: 2020 VS 2027
    Figure 10. Pain Relief Application Case Studies
    Figure 11. Anesthesia Application Case Studies
    Figure 12. Narcotic (Opioid) Drugs Report Years Considered
    Figure 13. Global Narcotic (Opioid) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Narcotic (Opioid) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Narcotic (Opioid) Drugs Market Share by Regions: 2020 VS 2027
    Figure 16. Global Narcotic (Opioid) Drugs Market Share by Regions (2022-2027)
    Figure 17. Global Narcotic (Opioid) Drugs Market Share by Players in 2020
    Figure 18. Global Top Narcotic (Opioid) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcotic (Opioid) Drugs as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Narcotic (Opioid) Drugs Revenue in 2020
    Figure 20. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2016-2021)
    Figure 21. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2022-2027)
    Figure 22. North America Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Narcotic (Opioid) Drugs Market Share by Type (2016-2027)
    Figure 24. North America Narcotic (Opioid) Drugs Market Share by Application (2016-2027)
    Figure 25. North America Narcotic (Opioid) Drugs Market Share by Country (2016-2027)
    Figure 26. United States Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Narcotic (Opioid) Drugs Market Share by Type (2016-2027)
    Figure 30. Europe Narcotic (Opioid) Drugs Market Share by Application (2016-2027)
    Figure 31. Europe Narcotic (Opioid) Drugs Market Share by Country (2016-2027)
    Figure 32. Germany Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Narcotic (Opioid) Drugs Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Narcotic (Opioid) Drugs Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Narcotic (Opioid) Drugs Market Share by Region (2016-2027)
    Figure 42. China Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Narcotic (Opioid) Drugs Market Share by Type (2016-2027)
    Figure 50. Latin America Narcotic (Opioid) Drugs Market Share by Application (2016-2027)
    Figure 51. Latin America Narcotic (Opioid) Drugs Market Share by Country (2016-2027)
    Figure 52. Mexico Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Narcotic (Opioid) Drugs Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Narcotic (Opioid) Drugs Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Narcotic (Opioid) Drugs Market Share by Country (2016-2027)
    Figure 58. Turkey Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Pfizer Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 62. Teva Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 63. Purdue Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 64. Mallinckrodt Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 65. Amneal Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 66. Collegium Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 67. Johnson & Johnson Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 68. Merck Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 69. Mylan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 70. Hikma Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 71. Sun Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 72. Endo Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 73. Allergan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Merck
Mylan
Hikma Pharmaceuticals
Sun Pharma
Endo Pharmaceuticals
Allergan
Frequently Asked Questions
Narcotic (Opioid) Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Narcotic (Opioid) Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Narcotic (Opioid) Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Mecobalamin

Market Analysis and Insights: Global Mecobalamin Market
The global Mecobalamin mark ... Read More